SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-073941
Filing Date
2023-03-17
Accepted
2023-03-17 16:30:54
Documents
13
Period of Report
2023-03-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d418205d8k.htm   iXBRL 8-K 30299
2 EX-10.1 d418205dex101.htm EX-10.1 20894
  Complete submission text file 0001193125-23-073941.txt   183569

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pkbo-20230313.xsd EX-101.SCH 2500
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pkbo-20230313_lab.xml EX-101.LAB 18731
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pkbo-20230313_pre.xml EX-101.PRE 11677
7 EXTRACTED XBRL INSTANCE DOCUMENT d418205d8k_htm.xml XML 3618
Mailing Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303
Business Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303 (650) 549-9103
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39951 | Film No.: 23743059
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences